Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01967082
Other study ID # 2013-0369
Secondary ID NCI-2018-0305420
Status Completed
Phase N/A
First received
Last updated
Start date October 16, 2013
Est. completion date January 8, 2020

Study information

Verified date January 2020
Source M.D. Anderson Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This trial studies how well APPSPIRE, a smartphone app, works in preventing students from smoking. Technology-driven intervention programs, such as the APPSPIRE app, have the potential to increase access to health behavior treatments and therapies, such as tobacco cessation support, and provide effective prevention messaging.


Description:

PRIMARY OBJECTIVES:

I. Develop a prototype of the APPSPIRE (phone application [app] of a smoking prevention interactive experience).

II. At post assessment, students enrolled in the study will qualitatively provide information about the usability and usefulness for the prevention and cessation sites.

III. Investigate frequency of use of and exposure to APPSPIRE modules via an objective measure of general use.

IV. Investigate how feasible the program will be. V. Obtain a maintained use of APPSPIRE with high completeness and extent of completion.

VI. Evaluate change in stage of change from baseline to about 1 and 4-month follow-ups among participants.

OUTLINE:

Participants attend an audio-taped focus group over 1 hour and are given the APPSPIRE app. After 1 and 4 months of using the app, participants complete a telephone survey over 1 hour to discuss how they liked the app and its usefulness.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date January 8, 2020
Est. primary completion date January 8, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 24 Years
Eligibility Inclusion Criteria:

- Student at Houston Community College (HCC)

- Speak and read English

- Own an iPhone

- Be enrolled in at least one class at HCC

- Provide current contact information

- Smoke 1 or more cigarettes a day (cessation group)

- Have access to the internet (cessation and prevention/advocacy groups)

- Evidence of smoking susceptibility as defined by the Smoking Susceptibility Scale

Exclusion Criteria:

- Does not plan to continue as a student at their campus sometime during the year of the study (cessation and prevention/advocacy groups)

- Current tobacco use (prevention/advocacy group)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
APPSPIRE
Given APPSPIRE app
Focus Group
Attend focus group
Other:
Survey Administration
Complete survey

Locations

Country Name City State
United States Houston Community College Houston Texas
United States M D Anderson Cancer Center Houston Texas

Sponsors (3)

Lead Sponsor Collaborator
M.D. Anderson Cancer Center National Cancer Institute (NCI), National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of APPSPIRE application (app) use Will be measured in minutes per day and with descriptive statistics. Will measure using mean, median and standard deviation for continuous variables. Up to 4 months
Primary The Feasibility of the tobacco control program. Feasibly will be measured by multiplying the variable of two concepts: ease of use and ability to fit the program into routine schedules. Up to 4 months
Primary The Completeness with the Percentages of Participants surveyed. Completeness will be measured as the percentage of participants who continue to use AppSPIRE until the 4 month follow up survey. Up to 4 months
Primary The extent of completion for the modules AppSPIRE. The extent of completion includes the various modules of AppSPIRE. High extent of completion is obtained if 75% of the participants have completed all modules of AppSPIRE. Up to 4 months
Primary The Stages of the Change Scale A validated measure, The Stages of Change Scale, will be used to clarify smokers into 3 categories: pre-contemplation, contemplation and preparation. Baseline up to 4 months
See also
  Status Clinical Trial Phase
Recruiting NCT03691350 - Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs Early Phase 1
Recruiting NCT03865472 - rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers N/A
Active, not recruiting NCT02271919 - Varenicline and Combined NRT for Smoking Cessation Phase 4
Withdrawn NCT03668769 - Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking N/A
Completed NCT02575885 - Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers N/A
Completed NCT04060446 - Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation in Current Every Day Cigarette Smokers
Completed NCT00941395 - Enhanced Smoking Cessation for University Students N/A
Recruiting NCT03199651 - Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer N/A
Recruiting NCT03824535 - 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules Phase 2
Completed NCT00468234 - Validation of Biomarkers of Exposure and Host Response N/A
Completed NCT00850954 - Project CASA in Promoting Smoke-Free Indoor Air Policy in Mexican American Households N/A
Active, not recruiting NCT02697227 - Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation N/A
Completed NCT03669120 - Tailored Smoking Cessation Intervention in Promoting Sexual and Gender Minority Smokers to Quit Smoking N/A
Completed NCT00948129 - Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers N/A